Coronavirus (Covid-19): check the list of all available scientific literature up to today

Coronavirus (Covid-19): check the list of all available scientific literature up to today

This is the whole list of all scientific articles about COVID-19 available in the medical literature, according to Pubmed. Guess what? Almost half of them are written in chinese. No wonder that last year China bet USA in number of scientific papers produced.

From the total of 45 papers, 8 papers were published in 2019 and 38  papers have already been published this year, as of March 18 2020 when the research was conducted. Its quite come literature being produced for this short amount of time, isn’t it?

Thanks to the chinese researchers, the world can understand a little more about what’s happening and learn fast with each other experience. This is probably the biggest scientific trend of this year, as happened with Zika virus the other year… way too many viruses to deal with. One may say that this is the kind of “war” we will have to face to prevent a huge decline in humankind.

Scientific publishers are also making a huge effort to make public health evidence and small scale studies reports available as soon as possible, sometimes published the very same day they are submitted.

There are 45 scientific papers published about coronavirus (covid-19), we will highlight the most interesting ones in a series of posts, starting today.

This is the response we all wanted from pre-print publication, isn’t it? It’s happening.  See below the list of all scientific literatura available for COVID-19 coronavirus:

1: Ren SY, Gao RD, Chen YL. Fear can be more harmful than the severe acute respiratory syndrome corona virus 2 in controlling the corona virus disease 2019 epidemic. World J Clin Cases. 2020 Feb 26;8(4):652-657.

2: Ezzat K, Pernemalm M, Pålsson S, Roberts TC, Järver P, Dondalska A, Bestas B, Sobkowiak MJ, Levänen B, Sköld M, Thompson EA, Saher O, Kari OK, Lajunen T, Sverremark Ekström E, Nilsson C, Ishchenko Y, Malm T, Wood MJA, Power UF, Masich S, Lindén A, Sandberg JK, Lehtiö J, Spetz AL, El Andaloussi S. The viral protein corona directs viral pathogenesis and amyloid aggregation. Nat Commun. 2019 May 27;10(1):2331.

3: Liang H, Acharya G. Novel coronavirus disease (COVID-19) in pregnancy: What clinical recommendations to follow? Acta Obstet Gynecol Scand. 2020 Mar 5.

4: Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020 Apr;79:104212.

5: Yang P, Liu P, Li D, Zhao D. Corona Virus Disease 2019, a growing threat to children? J Infect. 2020 Mar 3:S0163-4453(20)30105-5.

6: Yang HY, Duan GC. [Analysis on the epidemic factors for the Corona Virus Disease]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Mar 3;54(0):E021. Chinese.

7: Chen C, Zhang XR, Ju ZY, He WF. [Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies]. Zhonghua Shao Shang Za Zhi. 2020 Mar 1;36(0):E005.

8: Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L, Huang H, Li C. Chest CT Findings in Patients with Corona Virus Disease 2019 and its Relationship with Clinical Features. Invest Radiol. 2020 Feb 21.

9: Zhang HW, Yu J, Xu HJ, Lei Y, Pu ZH, Dai WC, Lin F, Wang YL, Wu XL, Liu LH, Li M, Mo YQ, Zhang H, Luo SP, Chen H, Lyu GW, Zhou ZG, Liu WM, Liu XL, Song HY, Chen FZ, Zeng L, Zhong H, Guo TT, Hu YQ, Yang XX, Liu PN, Li DF. Corona Virus International Public Health Emergencies: Implications for Radiology Management. Acad Radiol. 2020 Feb 26:S1076-6332(20)30089-1.

10: Martinez MA. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother. 2020 Mar 9:AAC.00399-20.

11: Luo H, Tang QL, Shang YX, Liang SB, Yang M, Robinson N, Liu JP. Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chin J Integr Med. 2020 Feb 17.

12: Hu ZB, Ci C. [Screening and management of asymptomatic infection of corona virus disease 2019 (COVID-19)]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Mar 8;54(0):E025. Chinese.

13: Zhu ZB, Zhong CK, Zhang KX, Dong C, Peng H, Xu T, Wang AL, Guo ZR, Zhang YH. [Epidemic trend of corona virus disease 2019 (COVID-19) in mainland China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Mar 3;54(0):E022. .

14: Roth WK. History and Future of Nucleic Acid Amplification Technology Blood Donor Testing. Transfus Med Hemother. 2019 Apr;46(2):67-75.

15: Peng QY, Wang XT, Zhang LN; Chinese Critical Care Ultrasound Study Group (CCUSG). Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic. Intensive Care Med. 2020 Mar 12.

16: Rahman Qureshi UU, Saleem S, Khan A, Afzal MS, Ali MS, Ahmed H. Outbreak of novel Corona virus (2019-nCoV); implications for travelers to Pakistan. Travel Med Infect Dis. 2020 Feb 4:101571.

17: Deng L, Li C, Zeng Q, Liu X, Li X, Zhang H, Hong Z, Xia J. Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019:a retrospective cohort study. J Infect. 2020 Mar 11:S0163-4453(20)30113-4.

18: Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature. J Microbiol Immunol Infect. 2019 Jun;52(3):501-503.

19: Zhang S, Li H, Huang S, You W, Sun H. High-resolution CT features of 17 cases of Corona Virus Disease 2019 in Sichuan province, China. Eur Respir J. 2020 Mar 5:2000334.

20: Lu D, Wang H, Yu R, HuiYang, Zhao Y. Integrated infection control strategy to minimize nosocomial infection of corona virus disease 2019 among ENT healthcare workers. J Hosp Infect. 2020 Feb 27:S0195-6701(20)30092-X.

21: Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, Li J, Wang H, Yu L, Huang H, Qiu Y, Wei G, Fang Q, Zhou J, Sheng J, Liang T, Li L. [Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(1):0.

22: Yu GY, Lou Z, Zhang W. [Several suggestion of operation for colorectal cancer under the outbreak of Corona Virus Disease 19 in China]. Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Feb 19;23(3):9-11. Chinese.

23: Society of Child Health, Chinese Preventive Medicine Association. [Immunization recommendations and safety and immunogenicity on the delayed vaccination of non-national immunization program for the corona virus disease 2019 in China]. Zhonghua Er Ke Za Zhi. 2020 Feb 27;58(0):E010. Chinese.

24: Wang J, Liu J, Wang Y, Liu W, Chen X, Sun C, Shen X, Wang Q, Wu Y, Liang W, Ruan L. [Dynamic changes of chest CT imaging in patients with corona virus disease-19 (COVID-19)]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 24;49(1):0.

25: Sayed AS, Malek SS, Abushahba MF. Seroprevalence of Middle East Respiratory Syndrome Corona Virus in dromedaries and their traders in upper Egypt. J Infect Dev Ctries. 2020 Feb 29;14(2):191-198.

26: Cao J, Hu X, Cheng W, Yu L, Tu WJ, Liu Q. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. Intensive Care Med. 2020 Mar 2.

27: Winthrop KL. Who needs a Corona? Arthritis Rheumatol. 2020 Mar 17.

28: Yang HY, Xu J, Li Y, Liang X, Jin YF, Chen SY, Zhang RG, Zhang WD, Duan GC. [The preliminary analysis on the characteristics of the cluster for the Corona Virus Disease]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Mar 8;41(0):623-628.

29: Tramontano E, Corona A, Menéndez-Arias L. Ribonuclease H, an unexploited

target for antiviral intervention against HIV and hepatitis B virus. Antiviral

Res. 2019 Nov;171:104613. doi: 10.1016/j.antiviral.2019.104613. Epub 2019 Sep

21. PMID: 31550450.

30: Task Force of Pulmonary Function Testing and Clinical Respiratory Physiology, Chinese Association of Chest Physicians; Pulmonary Function Testing Group, Respiratory Therapeutics Group, Chinese Thoracic Society. [Expert consensus on Pulmonary Function Testing during the epidemic of Corona Virus Disease 2019]. Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 4;43(0):E032.

31: Zhou JQ, Dong W, Xu HL, Cai YM, Sheng DH, Wu FY, Liu YK, Tang JJ, Lin WD, Huang LF, Lu SL. [Attention should be paid to the exposure risk of patients with chronic wounds on the way to hospital during corona virus disease 2019 epidemic prevention and control]. Zhonghua Shao Shang Za Zhi. 2020 Feb 23;36(0):E003.

32: Liu Y, Chen H, Tang K, Guo Y. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect. 2020 Mar 4:S0163-4453(20)30109-2.

33: Xiong Z, Fu L, Zhou H, Liu JK, Wang AM, Huang Y, Huang X, Yi B, Wu J, Li CH, Quan J, Li M, Leng YS, Luo WJ, Hu CP, Liao WH. [Construction and evaluation of a novel diagnosis process for 2019-Corona Virus Disease]. Zhonghua Yi Xue Za Zhi. 2020 Mar 11;100(0):E019.

34: Al-Rabiaah A, Temsah MH, Al-Eyadhy AA, Hasan GM, Al-Zamil F, Al-Subaie S, Alsohime F, Jamal A, Alhaboob A, Al-Saadi B, Somily AM. Middle East RespiratorySyndrome-Corona Virus (MERS-CoV) associated stress among medical students at a university teaching hospital in Saudi Arabia. J Infect Public Health. 2020 Jan 27:S1876-0341(20)30005-8.

35: Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 Mar 11.

36: Wang D, Zhou M, Nie X, Qiu W, Yang M, Wang X, Xu T, Ye Z, Feng X, Xiao Y, Chen W. Epidemiological characteristics and transmission model of Corona Virus Disease 2019 in China. J Infect. 2020 Mar 11:S0163-4453(20)30120-1.

37: Murphy CJ, Chang HH, Falagan-Lotsch P, Gole MT, Hofmann DM, Hoang KNL, McClain SM, Meyer SM, Turner JG, Unnikrishnan M, Wu M, Zhang X, Zhang Y. Virus- Sized Gold Nanorods: Plasmonic Particles for Biology. Acc Chem Res. 2019 Aug 20;52(8):2124-2135.

38: Harun A, Beyza E. Viral and Atypical Bacterial Respiratory Infections in a University Teaching Hospital. Jpn J Infect Dis. 2019 Sep 19;72(5):318-322.

39: Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, Li C. The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia. Invest Radiol. 2020 Feb 29.

40: Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li X, Liu XY, Liu HM, Guo Z, Ren H, Wang Q. Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19. J Med Virol. 2020 Mar 17.

41: Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, Hsueh PR. Arguments in favor of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents. 2020 Mar 5:105933.

42: Wang J, Wang BJ, Yang JC, Wang MY, Chen C, Luo GX, He WF. [Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures]. Zhonghua Shao Shang Za Zhi. 2020 Mar 16;36(0):E006.

43: Uckeley ZM, Moeller R, Kühn LI, Nilsson E, Robens C, Lasswitz L, Lindqvist R, Lenman A, Passos V, Voss Y, Sommerauer C, Kampmann M, Goffinet C, Meissner F, Överby AK, Lozach PY, Gerold G. Quantitative Proteomics of Uukuniemi Virus-host Cell Interactions Reveals GBF1 as Proviral Host Factor for Phleboviruses. Mol Cell Proteomics. 2019 Dec;18(12):2401-2417.

44: Ran L, Chen X, Wang Y, Wu W, Zhang L, Tan X. Risk Factors of Healthcare Workers with Corona Virus Disease 2019: A Retrospective Cohort Study in a Designated Hospital of Wuhan in China. Clin Infect Dis. 2020 Mar 17:ciaa287.

45: Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association. [An update on the epidemiological characteristics of novel coronavirus pneumoniaCOVID-19].Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 14;41(2):139-144.

Fabricio Pamplona is the founder of Mind the Graph - a tool used by over 400K users in 60 countries. He has a Ph.D. and solid scientific background in Psychopharmacology and experience as a Guest Researcher at the Max Planck Institute of Psychiatry (Germany) and Researcher in D'Or Institute for Research and Education (IDOR, Brazil). Fabricio holds over 2500 citations in Google Scholar. He has 10 years of experience in small innovative businesses, with relevant experience in product design and innovation management. Connect with him on LinkedIn - Fabricio Pamplona.